Wakefield Asset Management L »

Vertex Pharmaceuticals Incorporated shares owned by Wakefield Asset Management L

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Wakefield Asset Management L from 13F filings

Historical chart of Wakefield Asset Management L investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Wakefield Asset Management L consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Wakefield Asset Management L

Quarter filed Position value Share count Share price at filing
2025-09-30 $500k 1.3k 391.64
2025-06-30 $568k 1.3k 445.20
2025-03-31 $619k 1.3k 484.82
2022-03-31 $3.1M 12k 260.93

More positions owned by Wakefield Asset Management L

Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Core Msci Emkt (IEMG)
JPMorgan Chase & Co. (JPM)
Proshares Tr Short Qqq (PSQ)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Netflix (NFLX)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Newmont Mining Corporation (NEM)
Alphabet Cap Stk Cl A (GOOGL)
Lam Research Corp Com New (LRCX)
Trane Technologies SHS (TT)
Technipfmc (FTI)

View all positions for Wakefield Asset Management L

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated